MicroRNA-205 inhibits Src-mediated oncogenic pathways in renal cancer

Cancer Research

Volumn 71, Issue 7, 2011, Pages 2611-2621

  Majid, Shahana ^a   Saini, Sharanjot ^a   Dar, Altaf A ^b   Hirata, Hiroshi ^a   Shahryari, Varahram ^a   Tanaka, Yuichiro ^a   Yamamura, Soichiro ^a   Ueno, Koji ^a   Zaman, Mohd Saif ^a   Singh, Kamaldeep ^a   Chang, Inik ^a   Deng, Guoren ^a   Dahiya, Rajvir ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; FOCAL ADHESION KINASE; MICRORNA; MICRORNA 205; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN TYROSINE KINASE; STAT3 PROTEIN; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; APOPTOSIS; ARTICLE; CANCER CELL; CANCER INHIBITION; CANCER INVASION; CELL CYCLE ARREST; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL MIGRATION; CELL MOTILITY; CELL PROLIFERATION; COLONY FORMATION; CONTROLLED STUDY; CYCLIN D1 GENE; ENZYME INHIBITION; GENE; GENE MUTATION; GENE OVEREXPRESSION; GENE SEQUENCE; HUMAN; HUMAN CELL; HUMAN TISSUE; KIDNEY CANCER; LYN GENE; ONCOGENE C MYC; PLASMID; PRIORITY JOURNAL; PROTEIN EXPRESSION; SRC GENE; TISSUE SECTION; YES GENE;

APOPTOSIS; CARCINOMA, RENAL CELL; CELL CYCLE; CELL GROWTH PROCESSES; CELL LINE, TUMOR; CELL MOVEMENT; DOWN-REGULATION; HUMANS; KIDNEY NEOPLASMS; MAP KINASE SIGNALING SYSTEM; MICRORNAS; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; PROTO-ONCOGENE PROTEINS C-YES; RAF KINASES; RAS PROTEINS; RNA, SMALL INTERFERING; SRC-FAMILY KINASES;

EID: 79953331942     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-10-3666     Document Type: Article

References (48)

1. Summy JM, Gallick GE. Src family kinases in tumor progression and metastasis. Cancer Metastasis Rev 2003;22:337-58. (Pubitemid 36791891)
2. Thomas SM, Brugge JS. Cellular functions regulated by Src family kinases. Annu Rev Cell Dev Biol 1997;13:513-609. (Pubitemid 28034534)
3. Martin GS. The hunting of the Src. Nat Rev Mol Cell Biol 2001;2:467-75.
4. Park SI, Shah AN, Zhang J, Gallick GE. Regulation of angiogenesis and vascular permeability by Src family kinases: opportunities for therapeutic treatment of solid tumors. Expert Opin Ther Targets 2007;11:1207-17. (Pubitemid 47527325)
5. Stein PL, Vogel H, Soriano P. Combined deficiencies of Src, Fyn, and Yes tyrosine kinases in mutant mice. Genes Dev 1994;8:1999-2007.
6. Ito H, Gardner-Thorpe J, Zinner MJ, Ashley SW, Whang EE. Inhibition of tyrosine kinase Src suppresses pancreatic cancer invasiveness. Surgery 2003;134:221-6. (Pubitemid 37070342)
7. Cartwright CA, Meisler AI, Eckhart W. Activation of the pp60c-src protein kinase is an early event in colonic carcinogenesis. Proc Natl Acad Sci U S A 1990;87:558-62.
8. Lombardo LJ, Lee FY, Chen P, Norris D, Barrish JC, Behnia K, et al. Discovery of N-(2-chloro-6-methyl-phenyl)-2-(6-(4-(2-hydroxyethyl)-piperazin-1- yl)-2-methylpyrimidin-4-ylamino)thiazole-5-carboxamide (BMS-354825), a dual Src/Abl kinase inhibitor with potent antitumor activity in preclinical assays. J Med Chem 2004;47:6658-61. (Pubitemid 40053752)
9. Nam S, Kim D, Cheng JQ, Zhang S, Lee JH, Buettner R, et al. Action of the Src family kinase inhibitor, dasatinib (BMS-354825), on human prostate cancer cells. Cancer Res 2005;65:9185-9. (Pubitemid 41507982)
10. Parsons JT. Focal adhesion kinase: the first ten years. J Cell Sci 2003;116:1409-16. (Pubitemid 36527488)
11. Yonezawa Y, Nagashima Y, Sato H, Virgona N, Fukumoto K, Shirai S, et al. Contribution of the Src family of kinases to the appearance of malignant phenotypes in renal cancer cells. Mol Carcinog 2005;43:188-97. (Pubitemid 41134426)
12. Furstoss O, Dorey K, Simon V, Barila D, Superti-Furga G, Roche S. c-Abl is an effector of Src for growth factor-induced c-myc expression and DNA synthesis. EMBO J 2002;21:514-24. (Pubitemid 34174033)
13. Farkas A, Szatmari E, Orbok A, Wilhelm I, Wejksza K, Nagyoszi P, et al. Hyperosmotic mannitol induces Src kinase-dependent phosphoryla- tion of beta-catenin in cerebral endothelial cells. J Neurosci Res 2005;80:855-61. (Pubitemid 40961297)
14. Taj MM, Tawil RJ, Engstrom LD, Zeng Z, Hwang C, Sanda MG, et al. Mxi1, a Myc antagonist, suppresses proliferation of DU145 human prostate cells. Prostate 2001;47:194-204. (Pubitemid 32378371)
15. Devi GR, Oldenkamp JR, London CA, Iversen PL. Inhibition of human chorionic gonadotropin beta-subunit modulates the mitogenic effect of c-Myc in human prostate cancer cells. Prostate 2002;53:200-10. (Pubitemid 35266180)
16. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CACancer J Clin 2009;59:225-49.
17. Pantuck AJ, Zisman A, Belldegrun AS. The changing natural history of renal cell carcinoma. J Urol 2001;166:1611-23.
18. Hornstein E, Mansfield JH, Yekta S, Hu JK, Harfe BD, McManus MT, et al. The microRNA miR-196 acts upstream of Hoxb8 and Shh in limb development. Nature 2005;438:671-4. (Pubitemid 41740577)
19. Esau C, Kang X, Peralta E, Hanson E, Marcusson EG, Ravichandran LV, et al. MicroRNA-143 regulates adipocyte differentiation. J Biol Chem 2004;279:52361-5. (Pubitemid 39656612)
20. Leung AK, Sharp PA. microRNAs: a safeguard against turmoil?Cell 2007;130:581-5.
21. Garzon R, Calin GA, Croce CM. MicroRNAs in cancer. Annu Rev Med 2009;60:167-79.
22. Michael MZ, O' Connor SM, van Holst Pellekaan NG, Young GP, James RJ. Reduced accumulation of specific microRNAs in colorectal neoplasia. Mol Cancer Res 2003;1:882-91. (Pubitemid 37288707)
23. Yanaihara N, Caplen N, Bowman E, Seike M, Kumamoto K, Yi M, et al. Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 2006;9:189-98. (Pubitemid 43357945)
24. Saunders MA, Lim LP. (micro)Genomic medicine: microRNAs as therapeutics and biomarkers. RNA Biol 2009;6:324-8.
25. Bargaje R, Hariharan M, Scaria V, Pillai B. Consensus miRNA expression profiles derived from interplatform normalization of microarray data. RNA 2010;16:16-25.
26. Yi R, Fuchs E. MicroRNA-mediated control in the skin. Cell Death Differ 2010;17:229-35.
27. Bartels CL, Tsongalis GJ. MicroRNAs: novel biomarkers for human cancer. Clin Chem 2009;55:623-31.
28. Majid S, Dar AA, Ahmad AE, Hirata H, Kawakami K, Shahryari V, et al. BTG3 tumor suppressor gene promoter demethylation, histone modification and cell cycle arrest by genistein in renal cancer. Carcinogenesis 2009;30:662-70.
29. Majid S, Dar AA, Saini S, Yamamura S, Hirata H, Tanaka Y, et al. MicroRNA-205-directed transcriptional activation of tumor suppressor genes in prostate cancer. Cancer 2010;116:5637-49.
30. John B, Enright AJ, Aravin A, Tuschl T, Sander C, Marks DS. Human microRNA targets. PLoS Biol 2004;2:e363.
31. Betel D, Wilson M, Gabow A, Marks DS, Sander C. The microRNA.org resource: targets and expression. Nucleic Acids Res 2008;36:D149-53.
32. Lewis BP, Burge CB, Bartel DP. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are micro- RNA targets. Cell 2005;120:15-20. (Pubitemid 40094598)
33. Krek A, Grun D, Poy MN, Wolf R, Rosenberg L, Epstein EJ, et al. Combinatorial microRNA target predictions. Nat Genet 2005;37:495-500. (Pubitemid 40617277)
34. Trevino JG, Summy JM, Lesslie DP, Parikh NU, Hong DS, Lee FY, et al. Inhibition of SRC expression and activity inhibits tumor progression and metastasis of human pancreatic adenocarcinoma cells in an orthotopic nude mouse model. Am J Pathol 2006;168:962-72. (Pubitemid 43327748)
35. Chang YM, Bai L, Liu S, Yang JC, Kung HJ, Evans CP. Src family kinase oncogenic potential and pathways in prostate cancer as revealed by AZD0530. Oncogene 2008;27:6365-75.
36. Morin PJ. Beta-catenin signaling and cancer. Bioessays 1999;21:1021-30.
37. Prathapam T, Tegen S, Oskarsson T, Trumpp A, Martin GS. Activated Src abrogates the Myc requirement for the G0/G1 transition but not for the G1/S transition. Proc Natl Acad Sci U S A 2006;103:2695-700.
38. Bowman T, Broome MA, Sinibaldi D, Wharton W, Pledger WJ, Sedivy JM, et al. Stat3-mediated Myc expression is required for Src transformation and PDGF-induced mitogenesis. Proc Natl Acad Sci U S A 2001;98:7319-24. (Pubitemid 32567946)
39. Barone MV, Courtneidge SA. Myc but not Fos rescue of PDGF signalling block caused by kinase-inactive Src. Nature 1995;378:509-12.
40. Albanese C, Johnson J, Watanabe G, Eklund N, Vu D, Arnold A, et al. Transforming p21ras mutants and c-Ets-2 activate the cyclin D1 promoter through distinguishable regions. J Biol Chem 1995;270:23589-97.
41. Watanabe G, Howe A, Lee RJ, Albanese C, Shu IW, Karnezis AN, et al. Induction of cyclin D1 by simian virus 40 small tumor antigen. Proc Natl Acad Sci U S A 1996;93:12861-6. (Pubitemid 26382734)
42. Gottardo F, Liu CG, Ferracin M, Calin GA, Fassan M, Bassi P, et al. Micro-RNA profiling in kidney and bladder cancers. Urol Oncol 2007;25:387-92. (Pubitemid 47362758)
43. Sempere LF, Christensen M, Silahtaroglu A, Bak M, Heath CV, Schwartz G, et al. Altered microRNA expression confined to specific epithelial cell subpopulations in breast cancer. Cancer Res 2007;67:11612-20.
44. Nam S, Buettner R, Turkson J, Kim D, Cheng JQ, Muehlbeyer S, et al. Indirubin derivatives inhibit Stat3 signaling and induce apoptosis in human cancer cells. Proc Natl Acad Sci U S A 2005;102:5998-6003. (Pubitemid 40594244)
45. Shah AN, Gallick GE. Src, chemoresistance and epithelial to mesenchymal transition: are they related?Anticancer Drugs 2007;18:371-5.
46. Heidenreich A, Varga Z, Von Knobloch R. Extended pelvic lymphadenectomy in patients undergoing radical prostatectomy: high incidence of lymph node metastasis. J Urol 2002;167:1681-6. (Pubitemid 34240702)
47. Gray MJ, Zhang J, Ellis LM, Semenza GL, Evans DB, Watowich SS, et al. HIF-1alpha, STAT3, CBP/p300 and Ref-1/APE are components of a transcriptional complex that regulates Src-dependent hypoxiainduced expression of VEGF in pancreatic and prostate carcinomas. Oncogene 2005;24:3110-20. (Pubitemid 40695080)
48. Criscuoli ML, Nguyen M, Eliceiri BP. Tumor metastasis but not tumor growth is dependent on Src-mediated vascular permeability. Blood 2005;105:1508-14. (Pubitemid 40223667)